Surgery Insight: Surgical management of pancreatic cancer

Nature Clinical Practice Oncology

Volumn 4, Issue 9, 2007, Pages 526-535

  Michalski, Christoph W ^a   Weitz, Jürgen ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREAS FISTULA; PANCREAS RESECTION; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURGICAL APPROACH; SURGICAL RISK; SURGICAL STAPLING; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; TREATMENT INDICATION; VASCULAR SURGERY;

CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; MALE; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; TREATMENT OUTCOME;

EID: 34548432667     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0925     Document Type: Review

References (102)

1. Jemal A et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66
2. Bramhall SR et al. (1995) Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study. Br J Surg 82: 111-115
3. van Heek NT et al. (2005) Hospital volume and mortality after pancreatic resection: A systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242: 781-788
4. Carpelan-Holmstrom M et al. (2005) Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54: 385-387
5. Kleeff J et al. (2006) Pancreatic cancer: From bench to 5-year survival. Pancreas 33: 111-118
6. Sobin LH and Wittekind C (2002) UICC: TNM classification of malignant tumours. (Sixth edition) London: John Wiley & Sons
7. Lockhart AC et al. (2005) Treatment for pancreatic cancer: Current therapy and continued progress. Gastroenterology 128: 1642-1654
8. Spanknebel K and Conlon KC (2001) Advances in the surgical management of pancreatic cancer. Cancer J 7: 312-323
9. Muller MW et al. (2006) Middle segmental pancreatic resection: An option to treat benign pancreatic body lesions. Ann Surg 244 909-918
10. Kausch W (1912) Das carcinom der papilla duodeni und seine radikale entfernung [German]. Beitr Klin Chir 78: 439-486
11. Whipple AO et al. (1935) Treatment of carcinoma of the Ampulla of Vater. Ann Surg 102: 763-779
12. Gudjonsson B (1995) Carcinoma of the pancreas: Critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 181: 483-503
13. Trade M et al. (2001) Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area. Surg Clin North Am 8: 595-610
14. Berberat PO et al. (1999) Prevention and treatment of complications in pancreatic cancer surgery. Dig Surg 16: 327-336
15. McKay A et al. (2006) Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg 93: 929-936
16. Wente MN et al. (2007) Pancreaticojejunostomy versus pancreaticogastrostomy: Systematic review and meta-analysis. Am J Surg 193: 171-183
17. Sikora SS and MC Posner (1995) Management of the pancreatic stump following pancreaticoduodenectomy. Br J Surg 82: 1590-1597
18. Yeo CJ et al. (1995) A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222: 580-588
19. Hartell M et al. (2005) Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg 140: 1094-1099
20. Tani M et al. (2006) Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: Results of a prospective, randomized, controlled trial. Ann Surg 243: 316-320
21. Kleeff J et al. (2007) Distal pancreatectomy: Risk factors for surgical failure in 302 consecutive cases. Ann Surg 245: 573-582
22. Fernandez-del Castillo C et al. (1995) Standards for pancreatic resection in the 1990s. Arch Surg 130: 295-299
23. Lillemoe KD et al. (1999) Distal pancreatectomy: Indications and outcomes in 235 patients. Ann Surg 229: 693-698
24. Knaebel HP et al. (2005) Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg 92: 539-546
25. Schwarz RE et al. (1999) The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma. J Am Coll Surg 188: 516-521
26. Aldridge MC and RC Williamson (1991) Distal pancreatectomy with and without splenectomy. Br J Surg 78: 976-979
27. Buchler MW et al. (2003) Changes in morbidity after pancreatic resection: Toward the end of completion pancreatectomy. Arch Surg 138: 1310-1314
28. Karpoff HM et al. (2001) Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 136: 44-47
29. Yao CJ et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221: 721-731
30. Wagner M et al. (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91: 586-594
31. Wagner M et al. (2001) Pylorus-preserving total pancreatectomy: early and late results. Dig Surg 18: 188-195
32. Fuhrman GM et al. (1996) Rationale for an bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223: 154-162
33. Harrison LE et al. (1996) Isolated portal vein involvement in pancreatic adenocarcinoma: A contraindication for resection? Ann Surg 224: 342-347
34. Leach SD et al. (1998) Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85: 611-617
35. Siriwardana HP and Siriwardena AK (2006) Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93: 662-673
36. Tseng JF et al. (2004) Pancreaticoduodenectomy with vascular resection: Margin status and survival duration. J Gastrointest Surg 8: 935-949
37. Weitz J et al. (2007) Portal vein resection for advanced pancreatic head cancer. J Am Coll Surg 4: 712-716
38. Kondo S et al. (2003) Results of radical distal pancreatectomy with en bloc resection of the celiac artery for locally advanced cancer of the pancreatic body. Langenbecks Arch Surg 388: 101-106
39. Nakao A et al. (2006) Indications and techniques of extended resection for pancreatic cancer. World J Surg 30: 976-982
40. Ishikawa O et al. (1988) Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 208: 215-220
41. Manabe T et al. (1989) Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 64: 1132-1137
42. Michalski CW et al. (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94: 265-273
43. Riall TS et al. (2005) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma - part 3: Update on 5-year survival. J Gastrointest Surg 9: 1191-1204
44. Schwarz RE and Smith DD (2006) Extent of lymph node retrieval and pancreatic cancer survival: Information from a large US population database. Ann Surg Oncol 13: 1189-1200
45. Pawlik TM et al. (2005) Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 140 584-589
46. Hishinuma S et al. (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10: 511-518
47. Watson K (1944) Carcinoma of the Ampulla of Vater: Successful radical excision. Br J Surg 31: 368
48. Traverso LW and Longmire WP Jr (1978) Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 146: 959-962
49. Yeo CJ et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: Randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236: 355-366
50. Wenger FA et al. (1999) Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma - preliminary results of a prospective randomized study: Pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy [German]. Chirurg 70 1454-1459
51. Lin PW et al. (2005) Pancreaticoduodenectomy for pancreatic head cancer. PPPD versus Whipple procedure. Hepatogastroenterology 52: 1601-1604
52. Seiler CA et al. (2000) Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): Initial clinical results. J Gastrointest Surg 4: 443-452
53. Tran KT et al. (2004) Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: A prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240: 738-745
54. Diener MK et al. (2007) A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 245: 187-200
55. Horstmann O et al. (2004) Pylorus preservation has no impact on delayed gastric emptying after pancreatic head resection. Pancreas 28: 69-74
56. Pisters PW et al. (2001) Laparoscopy in the staging of pancreatic cancer. Br J Surg 88: 325-337
57. Ferrone CR et al. (2006) The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma. J Gastrointest Surg 10: 1347-1353
58. Ammori BJ and Baghdadi S (2006) Minimally invasive pancreatic surgery: The new frontier? Curr Gastroenterol Rep 8: 132-142
59. Croce E et al. (2005) Laparoscopic surgery of pancreatic cancer: state of the art. Hepatogastroenterology 52: 1889-1894
60. Halloran CM et al. (2002) Complications of pancreatic cancer resection. Dig Surg 19: 138-146
61. Yeo CJ et al. (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 226: 248-257
62. Rumstadt B et al. (1998) Hemorrhage after pancreatoduodenectomy. Ann Surg 227: 236-241
63. Bassi C et al. (2005) Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery 138: 8-13
64. Alexakis N et al. (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91: 1410-1427
65. van Berge Henegouwen MI et al. (1997) Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: Drainage versus resection of the pancreatic remnant. J Am Coll Surg 185 18-24
66. Aranha GV et al. (2006) Current management of pancreatic fistula after pancreaticoduodenectomy. Surgery 140: 561-568
67. Friess H et al. (1996) Inhibition of secretion in pancreas surgery reduces postoperative complication rate: A meta analysis of 4 multicenter studies [German]. Langenbecks Arch Chir Suppl Kongressbd 113: 255-258
68. Poon RT et al. (2002) Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy. Am J Surg 183: 42-52
69. Buchler M et al. (1992) Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163: 125-130
70. Montorsi M et al. (1995) Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: A prospective, controlled, randomized clinical trial. Surgery 117 26-31
71. Pederzoli P et al. (1994) Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 81: 265-269
72. Lowy AM et al. (1997) Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226: 632-641
73. Yeo CJ et al. (2000) Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232: 419-429
74. Koukoutsis I et al. (2006) Haemorrhage following pancreaticoduodenectomy: Risk factors and the importance of sentinel bleed. Dig Surg 23: 224-228
75. DeOliveira ML et al. (2006) Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 244: 931-937
76. Winter JM et al. (2006) 1,423 Pancreaticoduonectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 10: 1199-1200
77. Weitz J et al. (2004) Impact of volume and specialization for cancer surgery. Dig Surg 21: 253-261
78. Birkmeyer JD et al. (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346: 1128-1137
79. Birkmeyer JD et al. (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349: 2117-2127
80. Birkmeyer JD et al. (2006) Volume and process of care in high-risk cancer surgery. Cancer 106: 2476-2481
81. Riall TS et al. (2006) Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg 10: 1212-1224
82. Cameron JL et al. (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244: 10-15
83. Riall TS et al. (2006) Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140 764-772
84. Cameron JL et al. (1993) One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217: 430-435
85. Fong Y et al. (2005) Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 242: 540-544
86. Ferrone CR et al. (2005) Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol 23: 7529-7535
87. Ferrone CR et al. (2006) Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol 24: 2897-2902
88. Schniewind B et al. (2006) Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg 93: 1099-1107
89. Koninger J et al. (2007) Surgical palliation in patients with pancreatic cancer. Langenbecks Arch Surg 392: 13-21
90. Lillemoe KD et al. (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230: 322-328
91. Raty S et al. (2006) Complications of palliative hepaticojejunostomy and gastrojejunostomy in unresectable periampullary cancer: Patient- and disease-related risk factors. Hepatogastroenterology 53: 133-137
92. Van Heek NT et al. (2003) The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: A prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 238: 894-902
93. Bornman PC et al. (1986) Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet 1: 69-71
94. Shepherd HA et al. (1988) Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distall common bile duct: A randomized trial. Br J Surg 75: 1166-1168
95. Andersen JR et al. (1989) Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 30: 1132-1145
96. Smith AC et al. (1994) Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 344: 1655-1660
97. Reinders ME et al. (1995) Outcome of microscopically nonradical, subtotal pancreaticoduodenectomy (Whipple's resection) for treatment of pancreatic head tumors. World J Surg 19: 410-414
98. Lillemoe KD et al. (1996) Pancreaticoduodenectomy - does it have a role in the palliation of pancreatic cancer? Ann Surg 223: 718-725
99. Kuhlmann K et al. (2006) Microscopically incomplete resection offers acceptable palliation in pancreatic cancer. Surgery 139 188-196
100. Schniewind B et al. (2006) Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses. Ann Surg Oncol 13: 1403-1411
101. Kleeff J et al. (2007) Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg 245: 566-572
102. Shrikhande SV et al. (2007) Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 14: 118-127